Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of AM3 (Inmunoferón) in recurrent cystitis in women
2004-001512-31Phase 4Active
- Sponsor
- Cantabria Labs
- Start
- Sep 2004
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Inmunoferon in cystitis, sponsored by Cantabria Labs. Primary endpoint: Reduction of the recurrences. Started Sep 2004; status: active.
02
Drugs
Inmunoferon
03
Conditions
cystitis
Beyond the preview
Go deeper on 2004-001512-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001512-31.